| Name | Title | Contact Details |
|---|
Roxul Inc. is a Milton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
New England Biolabs is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New England Biolabs is based in Ipswich, MA. You can find more information on New England Biolabs at www.neb.com
NotifyMD is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bridges Integrative Health Svc is a Wheat Ridge, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.